TP53 and glioblastoma: In patients with glioblastoma undergoing radiation therapy, decreased Ki67 labeling index, O-methyl guanine methyl transferase (MGMT) methylation status, isocitrate dehydrogenase (IDH) mutation status, and absence of p53 overexpression have all also been associated with long-term survivors [101].